By Rosalind Watts, Sam Gandy, Alex Evans — 2019
Psychedelics offer a sense of expansive connectedness, just like astronauts have felt looking back to Earth from space.
Read on aeon.co
CLEAR ALL
The first randomized controlled trial to compare the illicit psychedelic psilocybin with a conventional selective serotonin reuptake inhibitor (SSRI) antidepressant found that the former improved symptoms of depression just as well on an established metric—and had fewer side effects.
1
Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.
Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.
Amazonian healing traditions collide with Western medical sensibilities.
2
To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.
A new generation of research into psilocybin could change how we treat numerous mental health conditions.
In a recent UK trial, 12 patients with major depression took a pill quite different to commonly prescribed antidepressants: 25mg of psilocybin, the psychedelic compound found in magic mushrooms.
At Imperial College we’ve been comparing psilocybin to conventional antidepressants—and the results are likely to be game-changing.
Often, disabled people have their disability treated, but they don’t have their emotional or spiritual needs addressed.
Depression and suicidal ideation are more likely among people with disabilities due to factors like abuse, isolation, and stressors related to poverty, among others.